IRWD
USDIronwood Pharmaceuticals Inc. Class A Common Stock
$1.870+0.060 (3.315%)
Real-time Price
Healthcare
Drug Manufacturers - Specialty & Generic
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.810
High
$1.890
Low
$1.760
Volume
0.59M
Company Fundamentals
Market Cap
303.8M
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
1.39M
Exchange
NMS
Currency
USD
52-Week Range
Low $0.53Current $1.870High $5.13
Related News
BusinessWire
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
– LINZESS® (Iinaclotide) U.S. net sales of $248 million in Q2 2025; EUTRx demand growth of 10% year-over-year – – Plans to align with FDA on confirmatory Phase 3 trial design in Q4 2025 – – Progressing
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.